Literature DB >> 1381103

Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.

H Arai1, Y Ichimiya, K Kosaka, T Moroji, R Iizuka.   

Abstract

Neurotransmitter-related markers were examined in Alzheimer-type dementia (ATD) and studied whether or not there is biochemical difference between the early- and late-onset sub-groups. Postmortem brains were obtained from neuropathologically diagnosed ATD patients and control subjects with no clinico-neuropathological findings indicative of neuropsychiatric diseases. Neurochemical data in the early- and late-onset groups were compared to the age-matched younger and older control groups, respectively, and expressed as a percentage of the mean value in the respective controls. Choline acetyltransferase activity and concentrations of serotonin and noradrenaline were more severely depleted in the early-onset ATD group than in the late-onset ATD group. These findings indicative of heterogeneity of ATD patients were discussed from the pathogenetic and therapeutic viewpoints.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381103     DOI: 10.1016/0278-5846(92)90106-o

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  14 in total

1.  Neurochemical parameters in senile dementia of the Alzheimer type. A longitudinal study in four cases.

Authors:  M Strittmatter; G Hamann; H Cramer; C Reuner; F Kuntzmann; D Strubel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 2.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

Review 3.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Hippocampal laminar distribution of tau relates to Alzheimer's disease and age of onset.

Authors:  Alon Seifan; Karen S Marder; Jesse Mez; James M Noble; Etty P Cortes; Jean Paul Vonsattel; Lawrence S Honig
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.

Authors:  Louise Ørum Olesen; Elena V Bouzinova; Maurizio Severino; Mithula Sivasaravanaparan; Jørgen Bo Hasselstrøm; Bente Finsen; Ove Wiborg
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

Review 6.  Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Authors:  Giuseppe Di Giovanni; Dubravka Svob Strac; Montse Sole; Mercedes Unzeta; Keith F Tipton; Dorotea Mück-Šeler; Irene Bolea; Laura Della Corte; Matea Nikolac Perkovic; Nela Pivac; Ilse J Smolders; Anna Stasiak; Wieslawa A Fogel; Philippe De Deurwaerdère
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

7.  Acteoside and Isoacteoside Protect Amyloid β Peptide Induced Cytotoxicity, Cognitive Deficit and Neurochemical Disturbances In Vitro and In Vivo.

Authors:  Young-Ji Shiao; Muh-Hwan Su; Hang-Ching Lin; Chi-Rei Wu
Journal:  Int J Mol Sci       Date:  2017-04-24       Impact factor: 5.923

8.  Epidemiology of early-onset dementia: a review of the literature.

Authors:  Renata Teles Vieira; Leonardo Caixeta; Sergio Machado; Adriana Cardoso Silva; Antonio Egidio Nardi; Oscar Arias-Carrión; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-06-14

9.  Reversal by aqueous extracts of Cistanche tubulosa from behavioral deficits in Alzheimer's disease-like rat model: relevance for amyloid deposition and central neurotransmitter function.

Authors:  Chi-Rei Wu; Hang-Ching Lin; Muh-Hwan Su
Journal:  BMC Complement Altern Med       Date:  2014-06-26       Impact factor: 3.659

Review 10.  Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.

Authors:  Lieven D Declercq; Rik Vandenberghe; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.